Skip to main content
Premium Trial:

Request an Annual Quote

Genetix, Nexcelom, Nikon

Premium
Genetix has expanded its CloneMedia range of semi-solid media products for mammalian cell cloning, the company announced this week.
 
The two new products – CloneMedia-HEK and CloneMedia-CHOK1 – are designed for the semi-solid cloning of suspension-adapted, serum-free HEK293 and CHOK1 cells, respectively.
 
The products were launched at the American Society of Cell Biology annual meeting in Washington, DC, Dec. 1-5.
 

 
Nexcelom this week announced that it has extended its product platform with the launch of the Cellometer Auto M10 automatic cell counter.
 
According to the company, the Auto M10 broadens the automated cell counting capabilities of the Cellometer Auto T4 by enabling higher magnification of cells as small as 2 µm, such as human platelets, yeasts, and algae.
 
Like the Cellometer Auto T4, the Cellometer Auto M10 has a footprint of 3.5 inches by 4 inches. The Auto M10 also uses Cellometer software on a PC and works with the Cellometer disposable counting chamber.
 
The Cellometer software automatically analyzes acquired cell images and measures cell concentration and viability. The Cellometer disposable counting chamber in the Auto M10 has four counting locations for acquiring cell data.
 
The manufacturer said that the Cellometer Auto M10 is most suitable for counting cells ranging from 2 µm to 12 µm that require higher magnification, while the Cellometer Auto T4 is most suitable for cell sizes greater than 5 µm.
 

 
Nikon launched its new Eclipse Ti series inverted microscope system at the American Society of Cell Biology annual meeting, held in Washington, DC, Dec. 1-5.
 

Available in three models, the new Ti series offers improved system speed, increased flexibility, and efficient multi-mode microscopy over the Eclipse TE2000 as part of a fully integrated microscope system that is appropriate for high-end research and live cell imaging.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.